Tumor microenvironment self-regulation: Bimetallic metal nanozyme-derived multifunctional nanodrug for optimizable cascade catalytic reaction-synergetic anti-tumor theranostics

化学 肿瘤微环境 级联 催化作用 双金属片 纳米技术 癌症研究 材料科学 生物化学 医学 肿瘤细胞 色谱法
作者
Xunan Jing,Lingjie Meng,Songqing Fan,Tingting Yang,Ning Zhang,Ruohan Xu,Xiaoping Zhao,Hongbo Yang,Zhiwei Yang,Daquan Wang,Yan Liang,Guoqing Zhou,Wenchen Ji,Junjun She
出处
期刊:Chemical Engineering Journal [Elsevier]
卷期号:442: 136096-136096 被引量:23
标识
DOI:10.1016/j.cej.2022.136096
摘要

• A multifunctional FeCu-GOx PNzyme was easily synthesized by a surfactant-free aqueous polymerization and coordination process. • Tumor microenvironment activated cascade catalytic reaction for enhanced oxidative stress. • FeCu-GOx PNzyme-MTO achieved multimodal imagings-guided photothermal-enhanced chemodynamic therapy and chemotherapy. The tumor microenvironment (TME) responsive multimodal theranostic nanoplatforms have attracted great attentions for precision medicine. To design well-defined cascade catalytic therapy and achieve the synergistic effect of different components in a nanoplatform, herein a spindle-shaped nanodrug termed as FeCu-GOx PNzyme-MTO was constructed by in-situ growth of bimetallic metal nanozyme (FeCu PNzyme), and simultaneous encapsulation of glucose oxidase (GOx) as well as fluorescent and chemotherapeutic mitoxanthrone (MTO). Interestingly, the obtained FeCu-GOx PNzyme is able to efficiently upregulate endogenous H 2 O 2 level and down-regulate acidity via inducing the catalytic decomposition of intratumoral glucose to gluconic acid and H 2 O 2 in TME, which is benefit to the cascade catalytic reactions for chemodynamic therapy (CDT). After efficient loading of MTO, such intelligent nanozyme triggers reactive oxygen species (ROS) generation in situ with tumor stimuli, self-augment ROS level upon intrinsic photothermal-conversion efficiency (53.05%) and glutathione (GSH) depletion, and specifically TME-responsive release of MTO to achieve high chemotherapeutic efficacy and biosafety. Both in vitro cellular assays and in vivo tumor-xenograft experiments proved that the tumor-specific cytotoxicity, biodegradability and potent antitumor efficiency of nanodrug, with co-contributions from highly cytotoxic ROS generated and precise drug delivery within tumors. This work thus presents the friendly construction of biocompatible FeCu-GOx PNzyme-MTO as effective nanodrug to provided a promising strategy for a new perspective on effective tumor therapy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
烫嘴普通话完成签到,获得积分10
2秒前
AteeqBaloch完成签到,获得积分10
3秒前
小吴同志发布了新的文献求助10
4秒前
蓝天碧海小西服完成签到,获得积分0
5秒前
8y24dp发布了新的文献求助10
5秒前
畅快的胡萝卜完成签到,获得积分10
5秒前
InfoNinja完成签到,获得积分0
8秒前
xin_you完成签到,获得积分10
10秒前
学术老6完成签到 ,获得积分10
12秒前
Man_proposes完成签到,获得积分10
12秒前
寻找土豆的灯完成签到 ,获得积分10
13秒前
乖乖完成签到,获得积分10
13秒前
CC完成签到 ,获得积分10
13秒前
欣慰的书本完成签到 ,获得积分10
14秒前
ymmmaomao23完成签到,获得积分10
14秒前
小胡完成签到,获得积分10
15秒前
佐为完成签到 ,获得积分10
16秒前
大东东发布了新的文献求助10
19秒前
19秒前
沙沙完成签到 ,获得积分10
20秒前
CC关注了科研通微信公众号
20秒前
21秒前
我是老大应助科研通管家采纳,获得10
22秒前
FashionBoy应助科研通管家采纳,获得30
22秒前
Tonnyjing应助科研通管家采纳,获得10
22秒前
薰硝壤应助科研通管家采纳,获得10
22秒前
Slence完成签到,获得积分10
23秒前
大旗发布了新的文献求助10
25秒前
顺利萧完成签到,获得积分10
25秒前
jz完成签到,获得积分10
26秒前
羽冰酒完成签到 ,获得积分10
28秒前
丘比特应助tyc采纳,获得10
28秒前
lan橙完成签到,获得积分10
28秒前
大东东完成签到,获得积分10
29秒前
老王完成签到 ,获得积分10
31秒前
orixero应助8y24dp采纳,获得10
32秒前
大旗完成签到,获得积分20
34秒前
一个稚气的小孩完成签到,获得积分10
35秒前
科研通AI2S应助熊boy采纳,获得10
36秒前
小吴同志完成签到,获得积分10
36秒前
高分求助中
좌파는 어떻게 좌파가 됐나:한국 급진노동운동의 형성과 궤적 2500
Sustainability in Tides Chemistry 1500
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Cognitive linguistics critical concepts in linguistics 800
Threaded Harmony: A Sustainable Approach to Fashion 799
Livre et militantisme : La Cité éditeur 1958-1967 500
氟盐冷却高温堆非能动余热排出性能及安全分析研究 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3052675
求助须知:如何正确求助?哪些是违规求助? 2709926
关于积分的说明 7418483
捐赠科研通 2354527
什么是DOI,文献DOI怎么找? 1246159
科研通“疑难数据库(出版商)”最低求助积分说明 605951
版权声明 595921